Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026)
Ceribell's (CBLL) quarterly Liabilities and Shareholders Equity came in at $166.3 million in Q2 2026, down 19.91% on a YoY basis from $207.7 million in Q2 2025, and down 6.59% quarter-over-quarter from $178.1 million in Q1 2026.
Analysis
Ceribell (CBLL) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $166.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 19.91% year-over-year to $166.3 million; the trailing twelve-month figure through Jun 2026 stood at $739.8 million (up 6.65% YoY), and the FY2025 full-year result was $195.8 million, down 13.14% from the prior year.
- Liabilities and Shareholders Equity declined to $166.3 million in Q2 2026 per CBLL's latest filing, from $178.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $225.4 million in Q4 2024 and bottomed at $47.1 million in Q3 2024.
- Historically, Liabilities and Shareholders Equity has averaged $165.8 million across 4 years, with a median of $195.8 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity jumped 323.99% in 2025, then fell 19.91% in 2026.
- Over 4 years, Liabilities and Shareholders Equity stood at $58.9 million in 2023, then surged by 282.56% to $225.4 million in 2024, then dropped by 13.14% to $195.8 million in 2025, then fell by 15.04% to $166.3 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $166.3 million, $178.1 million, and $195.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 37.25 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 2.41 Bn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 344.46 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 3.35 Bn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 283.00 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 5.72 Bn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 166.35 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | 30.24 Mn |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 1.10 Bn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | 153.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 166.35 Mn |
| Mar 31, 2026 | 178.08 Mn |
| Dec 31, 2025 | 195.80 Mn |
| Sep 30, 2025 | 199.53 Mn |
| Jun 30, 2025 | 207.69 Mn |
| Mar 31, 2025 | 213.47 Mn |
| Dec 31, 2024 | 225.41 Mn |
| Sep 30, 2024 | 47.06 Mn |
| Dec 31, 2023 | 58.92 Mn |